Scleroderma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 28: | Line 28: | ||
===Race=== | ===Race=== | ||
*Choctaw native americans from southeastern Oklahoma were reported to have much higher prevalence of scleroderma than the general population.<ref name="pmid8702445">{{cite journal |vauthors=Arnett FC, Howard RF, Tan F, Moulds JM, Bias WB, Durban E, Cameron HD, Paxton G, Hodge TJ, Weathers PE, Reveille JD |title=Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype |journal=Arthritis Rheum. |volume=39 |issue=8 |pages=1362–70 |date=August 1996 |pmid=8702445 |doi= |url=}}</ref> | *Choctaw native americans from southeastern Oklahoma were reported to have much higher prevalence of scleroderma than the general population.<ref name="pmid8702445">{{cite journal |vauthors=Arnett FC, Howard RF, Tan F, Moulds JM, Bias WB, Durban E, Cameron HD, Paxton G, Hodge TJ, Weathers PE, Reveille JD |title=Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype |journal=Arthritis Rheum. |volume=39 |issue=8 |pages=1362–70 |date=August 1996 |pmid=8702445 |doi= |url=}}</ref> | ||
* | *Scleroderma usually affects individuals of the African-American race more than the caucasian race.<ref name="pmid12628048">{{cite journal |vauthors=Reveille JD |title=Ethnicity and race and systemic sclerosis: how it affects susceptibility, severity, antibody genetics, and clinical manifestations |journal=Curr Rheumatol Rep |volume=5 |issue=2 |pages=160–7 |date=April 2003 |pmid=12628048 |doi= |url=}}</ref><ref name="pmid12905479">{{cite journal |vauthors=Mayes MD, Lacey JV, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, Schottenfeld D |title=Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population |journal=Arthritis Rheum. |volume=48 |issue=8 |pages=2246–55 |date=August 2003 |pmid=12905479 |doi=10.1002/art.11073 |url=}}</ref> | ||
===Gender=== | ===Gender=== | ||
Revision as of 19:33, 29 March 2018
|
Scleroderma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Scleroderma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Scleroderma epidemiology and demographics |
|
Risk calculators and risk factors for Scleroderma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]
Overview
Epidemiology and Demographics
Incidence
- The incidence of scleroderma is approximately 0.23 to 2.28 cases per 100,000 individuals worldwide.[1]
- The incidence of scleroderma is approximately 2 per 100,000 individuals in the United States.[2]
Prevalence
- The prevalence of scleroderma is approximately 5 to 30 cases per 100,000 individuals worldwide.[1]
- In 1990, the prevalence of scleroderma was estimated to be 27.6 cases per 100,000 individuals in the united states.[1]
- The prevalence of scleroderma is approximately 24 cases per 100,000 individuals in the United States.[2]
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- Patients of all age groups may develop [disease name].
- The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
- [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
- [Chronic disease name] is usually first diagnosed among [age group].
- [Acute disease name] commonly affects [age group].
Race
- Choctaw native americans from southeastern Oklahoma were reported to have much higher prevalence of scleroderma than the general population.[3]
- Scleroderma usually affects individuals of the African-American race more than the caucasian race.[4][5]
Gender
- Females are more commonly affected by scleroderma than males. The female to male ratio is approximately ranging from 3:1 to 14:1.[5][6]
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
Developing Countries
References
- ↑ 1.0 1.1 1.2 Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J (February 2008). "Incidence and prevalence of systemic sclerosis: a systematic literature review". Semin. Arthritis Rheum. 37 (4): 223–35. doi:10.1016/j.semarthrit.2007.05.003. PMID 17692364.
- ↑ 2.0 2.1 Mayes MD (May 2003). "Scleroderma epidemiology". Rheum. Dis. Clin. North Am. 29 (2): 239–54. PMID 12841293.
- ↑ Arnett FC, Howard RF, Tan F, Moulds JM, Bias WB, Durban E, Cameron HD, Paxton G, Hodge TJ, Weathers PE, Reveille JD (August 1996). "Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype". Arthritis Rheum. 39 (8): 1362–70. PMID 8702445.
- ↑ Reveille JD (April 2003). "Ethnicity and race and systemic sclerosis: how it affects susceptibility, severity, antibody genetics, and clinical manifestations". Curr Rheumatol Rep. 5 (2): 160–7. PMID 12628048.
- ↑ 5.0 5.1 Mayes MD, Lacey JV, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, Schottenfeld D (August 2003). "Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population". Arthritis Rheum. 48 (8): 2246–55. doi:10.1002/art.11073. PMID 12905479.
- ↑ "Systemic scleroderma - Genetics Home Reference".